Latest news
AstraZeneca (AZN) Stock Drops Amid Merger Talks with Bristol-Mye - GuruFocusGuruFocus · Mon, 03 Aug 2026 14:09:35 GMTAstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks - Business DayBusiness Day · Mon, 03 Aug 2026 13:04:41 GMTAstraZeneca tops pharma growth rankings while Bristol Myers trails amid merger talks (XLV:NYSEARCA) - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 12:11:56 GMTAstraZeneca shares drop 6% amid confusion over potential Bristol Myers Squibb buyout talks - PluangPluang · Mon, 03 Aug 2026 12:07:19 GMTAstraZeneca sinks more than 7% on the stock market amid rumors of a megamerger with Bristol Myers Squibb - DemócrataDemócrata · Mon, 03 Aug 2026 09:56:35 GMTAstraZeneca share prices drop amid £300bn mega-merger talks with US rival Bristol Myers Squibb - The IndependentThe Independent · Mon, 03 Aug 2026 09:35:00 GMTAstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb - uk.finance.yahoo.comuk.finance.yahoo.com · Mon, 03 Aug 2026 07:24:00 GMTBristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMT